{"url_path":"/sec/vsee/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-001883-index.html","accession_number":"0001185185-26-001883","cik":"0001864531","ticker":"VSEE","issuer_name":"VSEE HEALTH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-001883-index.html","primary_entity_key":"0001864531","primary_entity_name":"VSEE HEALTH, INC."},"word_count":443,"has_tables":true,"body_markdown":"**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n \n\n \n\n**FORM\n10-Q**\n\n \n\n \n\n \n\n**(Mark One)**\n\n**☒\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT\nOF 1934**\n\n \n\n**For\nthe quarterly period ended March 31, 2026**\n\n \n\n**or**\n\n \n\n**☐\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For\nthe transition period from            to         **\n\n** **\n\n**Commission\nFile Number: 001-41015**\n\n \n\n**VSee\nHealth, Inc.**\n\n**(Exact\nname of registrant as specified in its charter)**\n\n \n\n**Delaware** ** ** **86-2970927**\n\n**(State or other jurisdiction of incorporation or organization)**   **(I.R.S. Employer Identification Number)**\n\n \n\n**980\nN Federal Hwy**\n\n**Suite 304**\n\n**Boca\nRaton, FL 33432**\n\n**(Address\nof Principal Executive Offices)**\n\n \n\n**(754)\n231-1688**\n\n**(Registrant’s\ntelephone number)**\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\n**Title of Each Class**   **Trading symbol**   **Name of Exchange on which registered**\n\n**Common Stock, par value $0.0001 per share**   **VSEE**   **The Nasdaq Stock Market LLC**\n\n         \n\n**Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share**   **VSEEW**   **The Nasdaq Stock Market LLC**\n\n \n\nIndicate\nby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the\nSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to\nfile such reports), and (2) has been subject to such filing requirements for the past 90 days.\nYes ☒    No ☐\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405\nof Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant\nwas required to submit such files).  Yes ☒    No  ☐\n\n \n\nIndicate\nby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting\ncompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”\n“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐    \n\n           \n\nNon-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate\nby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes  ☐    No\n☒\n\n \n\nAs of May 14, 2026, there were 48,599,421 of the\nregistrant’s common stock outstanding.\n\n \n\n \n\n \n\n \n\n**TABLE\nOF CONTENTS**\n\n \n\n \n \n \n**Page**\n\n \n \n \n \n\n**Part I**\n[**Financial Information**](#a_001)"}